The inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparum

Journal of Pharmacology and Experimental Therapeutics

Volumn 327, Issue 2, 2008, Pages 511-517

  Van Schalkwyk, Donelly A ^a   Priebe, Waldemar ^c   Saliba, Kevin J ^a,b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b Canberra Hospital   (Australia)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMO 2 DEOXYGLUCOSE; 2 CHLORO 2 DEOXYGLUCOSE; CHLOROQUINE; DEOXYGLUCOSE; FLUORODEOXYGLUCOSE; HEXOKINASE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; GLYCOLYSIS; NONHUMAN; PH; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DEOXYGLUCOSE; FLUORODEOXYGLUCOSE F18; GLYCOLYSIS; HYDROGEN-ION CONCENTRATION; PHOSPHORYLATION; PLASMODIUM FALCIPARUM;

EID: 54349125693     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.141929     Document Type: Article

References (37)

1. Allen RJ and Kirk K (2004) The membrane potential of the intraerythrocytic malaria parasite Plasmodium falciparum. J Biol Chem 279:11264-11272.
2. Bell A (2005) Antimalarial drug synergism and antagonism: mechanistic and clinical significance. FEMS Microbiol Lett 253:171-184.
3. Bennett TN, Paguio M, Gligorijevic B, Seudieu C, Kosar AD, Davidson E, and Roepe PD (2004) Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrob Agents Chemother 48:1807-1810.
4. Desjardins RE, Canfield CJ, Haynes JD, and Chulay JD (1979) Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16:710-718.
5. Dieckmann-Schuppert A, Bender S, Odenthal-Schnittler M, Bause E, and Schwarz RT (1992) Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum. Eur J Biochem 205:815-825.
6. Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, and Rosenthal PJ (2007) Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA 297:2210-2219.
7. Fivelman QL, Adagu IS, and Warhurst DC (2004) Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob Agents Chemother 48:4097-4102.
8. Greco WR, Bravo G, and Parsons JC (1995) The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 47:331-385.
9. +-ATPase localized in plasma membranes of malaria parasite cells, Plasmodium falciparum, is involved in regional acidification of parasitized erythrocytes. J Biol Chem 275:34353-34358.
10. Ionita M, Krishna S, Léo PM, Morin C, and Patel AP (2007) Interaction of O-(undec-10-en)-yl-d-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT). Bioorg Med Chem Lett 17:4934-4937.
11. Joet T, Chotivanich K, Silamut K, Patel AP, Morin C, and Krishna S (2004) Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor. Biochem J 381:905-909.
12. Joet T, Eckstein-Ludwig U, Morin C, and Krishna S (2003) Validation of the hexose transporter of Plasmodium falciparum as a novel drug target. Proc Natl Acad Sci U S A 100:7476-7479.
13. Joet T, Holterman L, Stedman TT, Kocken CH, Van Der Wel A, Thomas AW, and Krishna S (2002) Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family. Biochem J 368:923-929.
14. Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, and Rex JH (2004) Combination antifungal therapy. Antimicrob Agents Chemother 48:693-715.
15. Kirk K, Horner HA, and Kirk J (1996) Glucose uptake in Plasmodium falciparum-infected erythrocytes is an equilibrative not an active process. Mol Biochem Parasitol 82:195-205.
16. Kremsner PG and Krishna S (2004) Antimalarial combinations. Lancet 364:285-294.
17. Krishna S, Woodrow CJ, Burchmore RJ, Saliba KJ, and Kirk K (2000) Hexose transport in asexual stages of Plasmodium falciparum and kinetoplastidae. Parasitol Today 16:516-521.
18. Lambros C and Vanderberg JP (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65:418-420.
19. Lampidis TJ, Kurtoglu M, Maher JC, Liu H, Krishan A, Sheft V, Szymanski S, Fokt I, Rudnicki WR, Ginalski K, et al. (2006) Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells." Cancer Chemother Pharmacol 58:725-734.
20. Lehane AM, Marchetti RV, Spry C, van Schalkwyk DA, Teng R, Kirk K, and Saliba KJ (2007) Feedback inhibition of pantothenate kinase regulates pantothenol uptake by the malaria parasite. J Biol Chem 282:25395-25405.
21. Nakada T, Kwee IL, and Conboy CB (1986) Noninvasive in vivo demonstration of 2-fluoro-2-deoxy-D-glucose metabolism beyond the hexokinase reaction in rat brain by 19F nuclear magnetic resonance spectroscopy. J Neurochem 46:198-201.
22. Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1.
23. Pfaller MA, Krogstad DJ, Parquette AR, and Nguyen-Dinh P (1982) Plasmodium falciparum: stage-specific lactate production in synchronized cultures. Exp Parasitol 54:391-396.
24. Rosenthal PJ (2002) Hydrolysis of erythrocyte proteins by proteases of malaria parasites. Curr Opin Hematol 9:140-145.
25. Roth EF Jr (1987) Malarial parasite hexokinase and hexokinase-dependent glutathione reduction in the Plasmodium falciparum-infected human erythrocyte. J Biol Chem 262:15678-15682.
26. +-pyrophosphatase. J Biol Chem 278:5605-5612.
27. Saliba KJ, Horner HA, and Kirk K (1998) Transport and metabolism of the essential vitamin pantothenic acid in human erythrocytes infected with the malaria parasite Plasmodium falciparum. J Biol Chem 273:10190- 10195.
28. +-ATPase. J Biol Chem 274:33213-33219.
29. Saliba KJ, Krishna S, and Kirk K (2004) Inhibition of hexose transport and abrogation of pH homeostasis in the intraerythrocytic malaria parasite by an O-3-hexose derivative. FEBS Lett 570:93-96.
30. Santos de Macedo C, Gerold P, Jung N, Azzouz N, Kimmel J, and Schwarz RT (2001) Inhibition of glycosyl-phosphatidylinositol biosynthesis in Plasmodium falciparum by C-2 substituted mannose analogues. Eur J Biochem 268:6221-6228.
31. Sherman IW (1998) Carbohydrate metabolism of asexual stages, in Malaria: Parasite Biology, Pathogenesis and Protection (Sherman IW ed) pp 135-143, American Society of Microbiology, Washington, DC.
32. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, and Riscoe M (2004) Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48:1803-1806.
33. 19F NMR spectroscopy study in the rat. NMR Biomed 16:494-502.
34. Udeinya IJ and Van Dyke K (1981) 2-Deoxyglucose: inhibition of parasitemia and of glucosamine incorporation into glycosylated macromolecules, in malarial parasites (Plasmodium falciparum). Pharmacology 23:171-175.
35. Vander Jagt DL, Hunsaker LA, Campos NM, and Baack BR (1990) D-Lactate production in erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol 42:277-284.
36. Woodrow CJ, Penny JI, and Krishna S (1999) Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter. J Biol Chem 274:7272-7277.
37. Wunsch S, Sanchez C, Gekle M, Kersting U, Fischer K, Horrocks P, and Lanzer M (1997) A method to measure the cytoplasmic pH of single, living Plasmodium falciparum parasites. Behring Inst Mitt 44-50.